Schett, G

Change history 25 February 2026 A Correction to this paper has been published: Abbreviations NF-B: Nuclear factor kappa B M: Macrophages IB: inhibitor of nuclear factor-B IKK: IB kinase TKIs: Tyrosine kinase inhibitors CAR-T: Chimeric antigen receptor T TLRs: toll-like receptors AnkRs: Ankyrin repeats PRR: Pattern recognition receptors RANK: receptor activator of nuclear factor kappa B NIK: NF-B-inducing kinase TRAF: TNF receptor associated factor IAP: inhibitors of apoptosis proteins ACP: Acid Phosphatase Akt: Protein Kinase B ALDH: Aldehyde Dehydrogenase ALDOA: Aldolase, Fructose-Bisphosphate A ALP: Alkaline Phosphatase ALT: Alanine Aminotransferase AST: Aspartate Aminotransferase ATG: Autophagy Related ATM: ATM Serine/Threonine Kinase ATP: Adenosine Triphosphate Bad: Bcl-2 Associated Agonist Of Cell Death Bax: Bcl-2 Associated X, Apoptosis Regulator Bcl-2: B-Cell CLL/Lymphoma 2 Bcl-xL: B-Cell Lymphoma-Extra Large Bid: BH3 Interacting Domain Death Agonist Bim: Bcl-2 Interacting Mediator Of Cell Death CAT: Catalase CCL-22: C-C Motif Chemokine Ligand 22 CCL4: C-C Motif Chemokine Ligand 4 CD: Cluster of Differentiation CDK: Cyclin Dependent Kinase c-FLIP: Cellular FLICE-Like Inhibitory Protein COX2: Cyclooxygenase 2 CRP: C-Reactive Protein DNA-PKcs: DNA-Dependent Protein Kinase, Catalytic Subunit DR6: Death Receptor 6 EGFR: Epidermal Growth Factor Receptor ENO1: Enolase 1 ERK: Extracellular Signal-Regulated Kinase FN: Fibronectin FOXP3: Forkhead Box P3 GAPDH: Glyceraldehyde-3-Phosphate Dehydrogenase G-CSF: Granulocyte Colony-Stimulating Factor GPI: Glucose-6-Phosphate Isomerase GPx: Glutathione Peroxidase GSH: Glutathione HDL: High-Density Lipoprotein HIF-1: Hypoxia-Inducible Factor 1 Subunit Alpha HK2: Hexokinase 2 HMGB1: High Mobility Group Box 1 HO-1: Heme Oxygenase 1 HSP90: Heat Shock Protein 90 HtrA-2: HtrA Serine Peptidase 2 IAP: Inhibitor of Apoptosis Protein ICAM: Intercellular Adhesion Molecule ICDH: Isocitrate Dehydrogenase IFN: Interferon IGF: Insulin-Like Growth Factor IGFBP: Insulin-Like Growth Factor Binding Protein IL: Interleukin iNOS: Inducible Nitric Oxide Synthase Keap1: Kelch-Like ECH-Associated Protein 1 LC3: Microtubule Associated Protein 1 Light Chain 3 LDHA: Lactate Dehydrogenase A LPO: Lactoperoxidase LPS: Lipopolysaccharide LXR: Liver X Receptor MAF1: MAF1 Homolog, Repressor Of RNA Polymerase III Transcription MCL-1: MCL1 Apoptosis Regulator, Bcl-2 Family Member M-CSF: Macrophage Colony-Stimulating Factor MDA: Malondialdehyde MDH: Malate Dehydrogenase MDM2: MDM2 Proto-Oncogene, E3 Ubiquitin Protein Ligase MMP: Matrix Metallopeptidase mTOR: Mechanistic Target Of Rapamycin Kinase NO: Nitric Oxide Nrf2: Nuclear Factor Erythroid 2-Related Factor 2 PARP: Poly(ADP-Ribose) Polymerase PDL1: Programmed Death-Ligand 1 PFKL: Phosphofructokinase, Liver Type PFKM: Phosphofructokinase, Muscle Type PGAM1: Phosphoglycerate Mutase 1 PGK1: Phosphoglycerate Kinase 1 P-gp: P-glycoprotein PI3K: Phosphoinositide 3-Kinase PTEN: Phosphatase And Tensin Homolog RBCs: Red Blood Cells ROS: Reactive Oxygen Species SHD: SH2 Domain Containing SMAC: Second Mitochondria-Derived Activator Of Caspase SOD: Superoxide Dismutase STAT3: Signal Transducer And Activator Of Transcription 3 STMN1: Stathmin 1 TAMs: Tumour associated macrophages TGF: Transforming Growth Factor TIMP2: TIMP Metallopeptidase Inhibitor 2 TME: Tumour microenvironment TNFAIP2: TNF Alpha Induced Protein 2 TNFR: Tumor Necrosis Factor Receptor TRAIL: TNF-Related Apoptosis-Inducing Ligand Treg cell: Regulatory T cell ULK1: Unc-51 Like Autophagy Activating Kinase 1 VEGF: Vascular Endothelial Growth Factor VEGFR: VEGF Receptor XIAP: X-Linked Inhibitor Of Apoptosis Protein -KGDH: Alpha-Ketoglutarate Dehydrogenase -SMA: Alpha-Smooth Muscle Actin H2AX: Gamma H2A Histone Family Member X References Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al

Are there any potential side effects of Glutathione Injections
There is not yet a proposed mechanism for how antibiotic treatment affects tight junction expression in specific regions of the brain in these studies, but it could be through changes in metabolite composition or cytokine involvement
von Locquenghien, M., Rozaln, C
Since some db/db mice succumbed to this treatment probably due to RIF toxicity at 16 mg/kg, we reduced the dose to 8 mg/kg and treated the animals 3 times weekly through oral gavage from day-4 onwards until 8 weeks post-infection